FindTrial
Sign In

Effect of Letrozole 2.5 mg or 5.0 mg for Ovulation Induction in Intrauterine Insemination in case of Unexplained Infertility

Effect of Letrozole 2.5 mg vs 5.0 mg for ovulation induction in case of unexplained infertility in intrauterine insemination - A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/048854
Enrollment
60
Registered
2023-01-10
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: N979- Female infertility, unspecified

Interventions

Intervention1: Ovulation Induction - letrozole 2.5 mg vs 5.0 mg: Letrozole in a dose of 2.5 mg or 5.0 mg orally is to be given for 5 days starting from day 3 to day 7 of menstrual cycle. the drug is t

Sponsors

Dr Rajendra Prasad Government Medical College , Tanda , Kangra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Unexplained infertility of at least 1 year duration Normal tubes on Hysterosalpingography Normal Semen Parameters of husband

Exclusion criteria

Exclusion criteria: Patients with grade 4 endometriosis Those with untreated endocrinological disorder Those not willing to participate

Design outcomes

Primary

MeasureTime frame
To compare ovulation rates in two groupsTimepoint: 2 weeks—

Secondary

MeasureTime frame
To compare pregnancy rates in two groupsTimepoint: After 4 weeks—

Countries

India

Contacts

Public ContactDr Ashok Verma

Dr Rajendra Prasad Government Medical College , Tanda , Kangra

drnehagoel7@gmail.com9896859060

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026